Intelligent Decision Analytics

Intelligent Decision Analytics (IDεA) is an information technology company specialized in the life sciences. At IDεA, we take an holistic approach to medical investments, by visualizing and quantifying the entire projects. Our services can be used to optimize the design of clinical trials, as well as to estimate and compare the values of entire medical investments. IDεA Software has been specifically developed to evaluate and maximize the return of clinical projects. By combining artificial intelligence with Monte Carlo simulations, IDεA Software enables creating millions of "what if" scenarios to estimate the predicted outcome of clinical trials. A unique feature is that IDεA Software can not only be used to evaluate and maximize the economic return of an investment, but also the corresponding for the societal impact it. IDεA Invest Estimate and maximize the value of your entire project with IDεA Invest. IDεA Invest visualizes, quantifies and optimizes questions from a wide range of aspects of your drug development process, such as revenue, timing, cost and risk. More specifically, questions such as the probability of your treatment making it to the market, the cost of it and how fast it can get there can be answered. IDεA Impact Invest We have designed IDεA Software to not only be applicable to regular investing, but also impact investing. Are you considering financing the development of a new drug and want to know the expected impact of it, per dollar spent? Or are you contemplating one or several drug development projects and want to compare it to other projects, in terms of predicted efficiency in creating the most impact? Or are you in the process of investing in a drug and want to detect the way of designing the clinical trial to create as much societal value per dollar spent as possible? These three are typical situations for when to use our service IDεA Impact Invest.